448 related articles for article (PubMed ID: 31337716)
1. Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment.
Landeras-Bueno S; Oda SI; Norris MJ; Li Salie Z; Guenaga J; Wyatt RT; Saphire EO
mBio; 2019 Jul; 10(4):. PubMed ID: 31337716
[TBL] [Abstract][Full Text] [Related]
2. Crystal Structure of the Marburg Virus Nucleoprotein Core Domain Chaperoned by a VP35 Peptide Reveals a Conserved Drug Target for Filovirus.
Zhu T; Song H; Peng R; Shi Y; Qi J; Gao GF
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659479
[TBL] [Abstract][Full Text] [Related]
3. Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 Peptide in Marburg Virus.
Liu B; Dong S; Li G; Wang W; Liu X; Wang Y; Yang C; Rao Z; Guo Y
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566377
[TBL] [Abstract][Full Text] [Related]
4. Crystal Structure of the Marburg Virus VP35 Oligomerization Domain.
Bruhn JF; Kirchdoerfer RN; Urata SM; Li S; Tickle IJ; Bricogne G; Saphire EO
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847355
[TBL] [Abstract][Full Text] [Related]
5. Ebola Virus Inclusion Body Formation and RNA Synthesis Are Controlled by a Novel Domain of Nucleoprotein Interacting with VP35.
Miyake T; Farley CM; Neubauer BE; Beddow TP; Hoenen T; Engel DA
J Virol; 2020 Jul; 94(16):. PubMed ID: 32493824
[TBL] [Abstract][Full Text] [Related]
6. Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function.
Prins KC; Binning JM; Shabman RS; Leung DW; Amarasinghe GK; Basler CF
J Virol; 2010 Oct; 84(20):10581-91. PubMed ID: 20686031
[TBL] [Abstract][Full Text] [Related]
7. Molecular architecture of the nucleoprotein C-terminal domain from the Ebola and Marburg viruses.
Baker LE; Ellena JF; Handing KB; Derewenda U; Utepbergenov D; Engel DA; Derewenda ZS
Acta Crystallogr D Struct Biol; 2016 Jan; 72(Pt 1):49-58. PubMed ID: 26894534
[TBL] [Abstract][Full Text] [Related]
8. In silico derived small molecules bind the filovirus VP35 protein and inhibit its polymerase cofactor activity.
Brown CS; Lee MS; Leung DW; Wang T; Xu W; Luthra P; Anantpadma M; Shabman RS; Melito LM; MacMillan KS; Borek DM; Otwinowski Z; Ramanan P; Stubbs AJ; Peterson DS; Binning JM; Tonelli M; Olson MA; Davey RA; Ready JM; Basler CF; Amarasinghe GK
J Mol Biol; 2014 May; 426(10):2045-58. PubMed ID: 24495995
[TBL] [Abstract][Full Text] [Related]
9. Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies.
Rahim MN; Wang M; Wang T; He S; Griffin BD; Kobasa D; Yang R; Du Z; Qiu X
Viruses; 2019 Mar; 11(3):. PubMed ID: 30875741
[TBL] [Abstract][Full Text] [Related]
10. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
[TBL] [Abstract][Full Text] [Related]
11. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
[TBL] [Abstract][Full Text] [Related]
12. A Sensitive in Vitro High-Throughput Screen To Identify Pan-filoviral Replication Inhibitors Targeting the VP35-NP Interface.
Liu G; Nash PJ; Johnson B; Pietzsch C; Ilagan MX; Bukreyev A; Basler CF; Bowlin TL; Moir DT; Leung DW; Amarasinghe GK
ACS Infect Dis; 2017 Mar; 3(3):190-198. PubMed ID: 28152588
[TBL] [Abstract][Full Text] [Related]
13. Structural insights into the interactions between lloviu virus VP30 and nucleoprotein.
Sun W; Luan F; Wang J; Ma L; Li X; Yang G; Hao C; Qin X; Dong S
Biochem Biophys Res Commun; 2022 Aug; 616():82-88. PubMed ID: 35649303
[TBL] [Abstract][Full Text] [Related]
14. The Ebola Virus VP30-NP Interaction Is a Regulator of Viral RNA Synthesis.
Kirchdoerfer RN; Moyer CL; Abelson DM; Saphire EO
PLoS Pathog; 2016 Oct; 12(10):e1005937. PubMed ID: 27755595
[TBL] [Abstract][Full Text] [Related]
15. Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.
Williams CG; Gibbons JS; Keiffer TR; Luthra P; Edwards MR; Basler CF
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295912
[TBL] [Abstract][Full Text] [Related]
16. Development of RNA aptamers targeting Ebola virus VP35.
Binning JM; Wang T; Luthra P; Shabman RS; Borek DM; Liu G; Xu W; Leung DW; Basler CF; Amarasinghe GK
Biochemistry; 2013 Nov; 52(47):8406-19. PubMed ID: 24067086
[TBL] [Abstract][Full Text] [Related]
17. Mapping of conserved and species-specific antibody epitopes on the Ebola virus nucleoprotein.
Changula K; Yoshida R; Noyori O; Marzi A; Miyamoto H; Ishijima M; Yokoyama A; Kajihara M; Feldmann H; Mweene AS; Takada A
Virus Res; 2013 Sep; 176(1-2):83-90. PubMed ID: 23702199
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated VP30 of Marburg Virus Is a Repressor of Transcription.
Tigabu B; Ramanathan P; Ivanov A; Lin X; Ilinykh PA; Parry CS; Freiberg AN; Nekhai S; Bukreyev A
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135121
[TBL] [Abstract][Full Text] [Related]
19. Filovirus proteins for antiviral drug discovery: Structure/function bases of the replication cycle.
Martin B; Canard B; Decroly E
Antiviral Res; 2017 May; 141():48-61. PubMed ID: 28192094
[TBL] [Abstract][Full Text] [Related]
20. Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism.
Bale S; Julien JP; Bornholdt ZA; Kimberlin CR; Halfmann P; Zandonatti MA; Kunert J; Kroon GJ; Kawaoka Y; MacRae IJ; Wilson IA; Saphire EO
PLoS Pathog; 2012 Sep; 8(9):e1002916. PubMed ID: 23028316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
